Bifidobacteria for treating cardiac conditions
AssigneeDupont Nutrition Biosciences Aps
InventorsLotta Stenman, Sampo Lahtinen, John Konhilas
Life of this patent
Estimating the term…
Abstract
This invention relates to new uses of Bifidobacteria (particularly, although not exclusively, probiotic Bifidobacteria), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of myocardial infarction, dilated cardiomyopathy, inflammatory heart disease (including endocarditis, inflammatory cardiomegaly and myocarditis), and congestive heart failure.
Claims28
A method for treating cardiovascular disease in a mammal in need thereof, wherein the method comprises administering an effective amount of a bacterium of the genus Bifidobacterium to the mammal for a period of at least 7 days and not exceeding 18 days, wherein the mammal is experiencing or displaying a pathology or symptomatology of the cardiovascular disease.
Dependencies are inferred from the claim text.